[1]
H. B. Balasubramanian et al., “Affinity of Nintedanib Towards New Candidate Target for Idiopathic Pulmonary Fibrosis”, Borneo J Pharm, vol. 7, no. 3, pp. 264–277, Aug. 2024, doi: 10.33084/bjop.v7i3.7218.